1. Home /
  2. PIPES

PIPES

'Pharma Bro' Shkreli is Jailed After Judge Revokes His $5 Million Bond

'Pharma Bro' Shkreli is Jailed After Judge Revokes His $5 Million Bond

Despite pleading with his judge through a letter, Martin Shkreli had his $5 million bail revoked and will sit in jail while he awaits sentencing on securities fraud conviction.

Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer

Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer

CEO Joseph Sardano says skin cancer is often catching up with people earlier in life than it used to.

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Former hedge funder and biotech CEO Martin Shkreli finds himself in limbo as a criminal jury now decides if allegations of fraud will put him in orange coveralls.

Medical Device Company Sells $13M in Stock at a Discount of More than 50%

Medical Device Company Sells $13M in Stock at a Discount of More than 50%

MRI Interventions has plans to jump from over-the-counter trading to a senior exchange, and just raised $13 million to fuel the company's growth.

Cowen to Sell 20% Stake to Conglomerate China Energy

Cowen to Sell 20% Stake to Conglomerate China Energy

CEFC will pay nearly a 30% premium for shares Cowen issues in a PIPE offering.

SEC Follow Canada's Lead and Suspends Trading in NewGen

SEC Follow Canada's Lead and Suspends Trading in NewGen

NewGen BioPharma saw its shares halted, with the SEC saying it had concerns regarding former officer and majority shareholder as well as whether public information was accurate.

Beware the Flood of Reg-Lite Listed Companies

Beware the Flood of Reg-Lite Listed Companies

The first company that need tell investors little about itself has hit the market, and is expected open the floodgates for more.

Another Way to Invest With the Smart Money: SPACs

Another Way to Invest With the Smart Money: SPACs

Once a shaky alternative to conventional IPOs, special-purpose acquisition companies let the public in on private equity bets.